MLVRX | VFINX | MLVRX / VFINX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 11 years | 48 years | - |
Gain YTD | 2.496 | 24.763 | 10% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 397M | 1.37T | 0% |
Annual Yield % from dividends | 1.05 | 1.24 | 85% |
Returns for 1 year | 3.79 | 25.40 | 15% |
Returns for 3 years | -10.08 | 28.04 | -36% |
Returns for 5 years | 17.04 | 84.83 | 20% |
Returns for 10 years | 84.30 | 186.19 | 45% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
DWOCX | 15.82 | 0.23 | +1.48% |
BNY Mellon Research Growth C | |||
SHSAX | 62.63 | 0.64 | +1.03% |
BlackRock Health Sciences Opps Inv A | |||
MFVNX | 12.03 | 0.11 | +0.92% |
MassMutual Equity Opports R3 | |||
TPLNX | 18.87 | 0.08 | +0.43% |
Timothy Plan Small Cap Value A | |||
FCGPX | 19.48 | 0.06 | +0.31% |
NYLI PineStone Global Equity Class P |